Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER).

Saved in:
Bibliographic Details
Title: Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER).
Authors: Fernandez, M., Calvo, I., Martinez, N., Herrero, M., Quijano, Y., Duran, H., Garcia-Aranda, M., Suarez, A., Lopez-Rios, F., Perez, D., Perea, S., Hidalgo, M., Garcia-Estevez, L.
Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p396-397. 2p.
Database: Academic Search Ultimate
Description
ISSN:00085472
DOI:10.1158/0008-5472.SABCS12-P1-14-10